The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics
Open accessAbstract
This is the second half of a two-part document updating the standard of care recommendations for spinal muscular atrophy published in 2007. This part includes updated recommendations on pulmonary management and acute care issues, and topics that have emerged in the last few years such as other organ involvement in the severe forms of spinal muscular atrophy and the role of medications. Ethical issues and the choice of palliative versus supportive care are also addressed. These recommendations are becoming increasingly relevant given recent clinical trials and the prospect that commercially available therapies will likely change the survival and natural history of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
Mendell, J. R., Al-Zaidy, S., Shell, R., Arnold, W. D., Rodino-Klapac, L. R., Prior, T. W., Lowes, L., Alfano, L., Berry, K., Church, K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1706198 · Cited by 2,381
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
Finkel, R. S., Mercuri, E., Darras, B. T., Connolly, A. M., Kuntz, N. L., Kirschner, J., Chiriboga, C. A., Saito, K., Servais, L., Tizzano, E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1702752 · Cited by 2,337
Self-citationFinkel, R. S., Chiriboga, C. A., Vajsar, J., Day, J. W., Montes, J., De Vivo, D. C., Yamashita, M., Rigo, F., Hung, G., Schneider, E., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31408-8 · Cited by 1,019
Self-citationConsensus Statement for Standard of Care in Spinal Muscular Atrophy
Wang, C. H., Finkel, R. S., Bertini, E. S., Schroth, M., Simonds, A., Wong, B., Aloysius, A., Morrison, L., Main, M., Crawford, T. O., et al. (2007) · Journal of Child Neurology · doi:10.1177/0883073807305788 · Cited by 961
Self-citationThe survival motor neuron protein in spinal muscular atrophy
Coovert, D. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.8.1205 · Cited by 714
Results from a phase 1 study of nusinersen (ISIS-SMN Rx ) in children with spinal muscular atrophy
Chiriboga, C. A., Swoboda, K. J., Darras, B. T., Iannaccone, S. T., Montes, J., De Vivo, D. C., Norris, D. A., Bennett, C. F., & Bishop, K. M. (2016) · Neurology · doi:10.1212/wnl.0000000000002445 · Cited by 612
Self-citationA Novel Function for SMN, the Spinal Muscular Atrophy Disease Gene Product, in Pre-mRNA Splicing
Pellizzoni, L., Kataoka, N., Charroux, B., & Dreyfuss, G. (1998) · Cell · doi:10.1016/s0092-8674(00)81632-3 · Cited by 558
Hull, J., Aniapravan, R., Chan, E., Chatwin, M., Forton, J., Gallagher, J., Gibson, N., Gordon, J., Hughes, I., McCulloch, R., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-201964 · Cited by 394
Self-citationSpinal muscular atrophy: going beyond the motor neuron
Hamilton, G., & Gillingwater, T. H. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.11.002 · Cited by 381
Classifying Recommendations for Clinical Practice Guidelines
Steering Committee on Quality Improvement and Management (2004) · Pediatrics · doi:10.1542/peds.2004-1260 · Cited by 322
Prospective cohort study of spinal muscular atrophy types 2 and 3
Kaufmann, P., McDermott, M. P., Darras, B. T., Finkel, R. S., Sproule, D. M., Kang, P. B., Oskoui, M., Constantinescu, A., Gooch, C. L., Foley, A. R., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318271f7e4 · Cited by 283
Self-citationSpinal muscular atrophy: a motor neuron disorder or a multi‐organ disease?
Shababi, M., Lorson, C. L., & Rudnik‐Schöneborn, S. S. (2014) · Journal of Anatomy · doi:10.1111/joa.12083 · Cited by 262
Hull, J. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-202043 · Cited by 241
Spinal muscular atrophy type 1: Management and outcomes
Bach, J. R., Baird, J. S., Plosky, D., Navado, J., & Weaver, B. (2002) · Pediatric Pulmonology · doi:10.1002/ppul.10110 · Cited by 221
Spinal muscular atrophy: mechanisms and therapeutic strategies
Lorson, C. L., Rindt, H., & Shababi, M. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq147 · Cited by 209 · cited 1×
“Recent reviews of the literature [50,51] identified a number of cases with congenital heart defects such as atrial or ventricular septal defects.”
Spinal Muscular Atrophy Type 1
Bach, J. R., Niranjan, V., & Weaver, B. (2000) · Chest · doi:10.1378/chest.117.4.1100 · Cited by 209
Cardiac defects contribute to the pathology of spinal muscular atrophy models
Shababi, M., Habibi, J., Yang, H. T., Vale, S. M., Sewell, W. A., & Lorson, C. L. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq329 · Cited by 207
Congenital heart disease is a feature of severe infantile spinal muscular atrophy
Rudnik-Schöneborn, S., Heller, R., Berg, C., Betzler, C., Grimm, T., Eggermann, T., Eggermann, K., Wirth, R., Wirth, B., & Zerres, K. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.057950 · Cited by 202
Self-citationGlucose metabolism and pancreatic defects in spinal muscular atrophy
Bowerman, M., Swoboda, K. J., Michalski, J., Wang, G., Reeks, C., Beauvais, A., Murphy, K., Woulfe, J., Screaton, R. A., Scott, F. W., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23582 · Cited by 189
Spinal Muscular Atrophy: Survival Pattern and Functional Status
Chung, B. H. Y., Wong, V. C. N., & Ip, P. (2004) · Pediatrics · doi:10.1542/peds.2004-0668 · Cited by 178
Vianello, A., Corrado, A., Arcaro, G., Gallan, F., Ori, C., Minuzzo, M., & Bevilacqua, M. (2005) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/01.phm.0000151941.97266.96 · Cited by 163
Pathophysiological Insights Derived by Natural History and Motor Function of Spinal Muscular Atrophy
Farrar, M. A., Vucic, S., Johnston, H. M., et al. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.05.067 · Cited by 148
Pilot trial of albuterol in spinal muscular atrophy
Kinali, M., Mercuri, E. M., Main, M. L., Biasia, F. D., Karatza, A., Higgins, R., Banks, L. M., Manzur, A. Y., & Muntoni, F. (2002) · Neurology · doi:10.1212/wnl.59.4.609 · Cited by 132
Self-citationBertini, E., Dessaud, É., Mercuri, E. M., Muntoni, F., Kirschner, J., Reid, C., Łusakowska, A., Comi, G. P., Cuisset, J., Abitbol, J., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30085-6 · Cited by 122
Self-citationDrug treatment for spinal muscular atrophy types II and III
Wadman, R. I., Bosboom, W. M., van der Pol, W. L., van den Berg, L. H., Wokke, J. H. J., Iannaccone, S. T., & Vrancken, A. F. J. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006282.pub4 · Cited by 109
Self-citationMitochondrial dysfunction in a neural cell model of spinal muscular atrophy
Acsádi, G., Lee, I., Li, X., Khaidakov, M., Pecinová, A., Parker, G. C., & Hüttemann, M. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22106 · Cited by 102
Tein, I., Sloane, A. E., Donner, E. J., Lehotay, D. C., Millington, D. S., & Kelley, R. I. (1995) · Pediatric Neurology · doi:10.1016/0887-8994(94)00100-g · Cited by 89
Medical Considerations of Long-Term Survival of Werdnig–Hoffmann Disease
Bach, J. R. (2007) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e31804b1d66 · Cited by 88
Kissel, J. T., Elsheikh, B., King, W. M., Freimer, M. L., Scott, C., Kolb, S. J., Reyna, S. P., Crawford, T. O., Simard, L. R., Krosschell, K. J., et al. (2013) · Muscle & Nerve · doi:10.1002/mus.23904 · Cited by 79
Self-citationGraham, R. J., Pemstein, D. M., & Curley, M. A. Q. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a00578 · Cited by 72
Self-citationXu, C.-C., Denton, K. R., Wang, Z.-B., Zhang, X., & Li, X. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.021766 · Cited by 69
218th ENMC International Workshop:
Finkel, R. S., Sejersen, T., Mercuri, E. M., Bertini, E., Chen, K., Crawford, T. O., Dubowitz, V., de Lemus, M., Graham, R. J., Davis, R. H., et al. (2017) · Neuromuscular Disorders · doi:10.1016/j.nmd.2017.02.014 · Cited by 67
Self-citationDrug treatment for spinal muscular atrophy type I
Wadman, R. I., Bosboom, W. M., van der Pol, W. L., van den Berg, L. H., Wokke, J. H. J., Iannaccone, S. T., & Vrancken, A. F. J. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006281.pub4 · Cited by 64
Self-citationPatients with severe muscle wasting are prone to develop hypoglycemia during fasting
Ørngreen, M. C., Zacho, M., Hebert, A. M., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000086813.59722.72 · Cited by 58
Noninvasive Ventilation in Children with Spinal Muscular Atrophy Types 1 and 2
Petrone, A., Pavone, M., Testa, M. B. C., Petreschi, F., Bertini, E., & Cutrera, R. (2007) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e31802ef774 · Cited by 57
Self-citationTizzano, E. F., Cabot, C., & Baiget, M. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65578-2 · Cited by 56
Abnormal fatty acid metabolism in spinal muscular atrophy may predispose to perioperative risks
Zolkipli‐Cunningham, Z., Sherlock, M. E., Biggar, W. D., Taylor, G. P., Hutchison, J. S., Peliowski, A., Alman, B. A., Ling, S. C., & Tein, I. (2012) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2012.01.004 · Cited by 53
1st Italian SMA Family Association Consensus Meeting:
Sansone, V., Racca, F., OTTONELLO, G., Vianello, A., Berardinelli, A. L., Crescimanno, G., Casiraghi, J. L., Agosto, C., Banfi, P. I., Baranello, G., et al. (2015) · Neuromuscular Disorders · doi:10.1016/j.nmd.2015.09.009 · Cited by 50
Threats to [ldquo ]informed[rdquo ] advance directives for the severely physically challenged?
Bach, J. R. (2003) · Archives of Physical Medicine and Rehabilitation · doi:10.1053/apmr.2003.50243 · Cited by 33
Lövgren, M., Sejersen, T., & Kreicbergs, U. C. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.04.062 · Cited by 33
Self-citationCardiac involvement in patients with spinal muscular atrophies.
Palladino, A., Passamano, L., Taglia, A., D′Ambrosio, P., Scutifero, M., Cecio, M. R., Picillo, E., Viggiano, E., Torre, Luca, F. D., et al. (2011) · Europe PMC (PubMed Central) · Cited by 32
Hyperleptinemia in children with autosomal recessive spinal muscular atrophy type I-III
Kölbel, H., Hauffa, B. P., Wudy, S. A., Bouikidis, A., Marina, A. D., & Schara, U. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173144 · Cited by 23
Spinal Muscular Atrophy Type I
Finkel, R. S., Bishop, K. M., & Nelson, R. M. (2016) · Journal of Child Neurology · doi:10.1177/0883073816671236 · Cited by 21
Self-citationDrug treatment for spinal muscular atrophy types II and III
Bosboom, W. M., Vrancken, A. F. J. E., van den Berg, L. H., Wokke, J. H. J., & Iannaccone, S. T. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006282.pub2 · Cited by 20
Self-citationSpinal Muscular Atrophy Type 1: Avoidance of Hospitalization by Respiratory Muscle Support
OTTONELLO, G., Mastella, C., Franceschi, A., Bosticco, D., Wolfler, A., Pedemonte, M., Esposito, I., & Gregoretti, C. (2011) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e318232883a · Cited by 18
Cardiac Function in Types II and III Spinal Muscular Atrophy: Should We Change Standards of Care?
Bianco, F., Pane, M., D’Amico, A., Messina, S., Delogu, A. B., Sorarú, G., Pera, M. C., Mongini, T., Politano, L., Baranello, G., et al. (2014) · Neuropediatrics · doi:10.1055/s-0034-1395348 · Cited by 10
Self-citationPrice (1999) · doi:10.1002/1531-8249(199903)45:3
Cited by
Day, J. W., Finkel, R. S., Chiriboga, C. A., Connolly, A. M., Crawford, T. O., Darras, B. T., Iannaccone, S. T., Kuntz, N. L., Peña, L. D. M., Shieh, P. B., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00001-6 · Cited by 494
Self-citationMercuri, E., Sumner, C. J., Muntoni, F., Darras, B. T., & Finkel, R. S. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00380-8 · Cited by 430
Self-citationSchorling, D. C., Pechmann, A., & Kirschner, J. (2020) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-190424 · Cited by 276
Self-citationWirth, B., Karakaya, M., Kye, M. J., & Mendoza-Ferreira, N. (2020) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-102319-103602 · Cited by 255
Self-citationHealth outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy
Al‐Zaidy, S., Pickard, A. S., Kotha, K., Alfano, L. N., Lowes, L., Paul, G., Church, K., Lehman, K., Sproule, D. M., Dabbous, O., et al. (2019) · Pediatric Pulmonology · doi:10.1002/ppul.24203 · Cited by 216
Metadata
- Authors
- Finkel, R. S., Mercuri, E., Meyer, O. H., Simonds, A. K., Schroth, M. K., Graham, R. J., Kirschner, J., Iannaccone, S. T., Crawford, T. O., Woods, S., Muntoni, F., Wirth, B., Montes, J., Main, M., Mazzone, E. S., Vitale, M., Snyder, B., Quijano-Roy, S., Bertini, E., Davis, R. H., Qian, Y., & Sejersen, T.
- Venue
- Neuromuscular Disorders
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 28
- Issue
- 3
- Pages
- 197-207
- ISSN
- 0960-8966 (ISSN-L)
- OpenAlex
- W2769295220
- Cited by
- 684
- References
- 48
- FWCI
- 22.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.